Last reviewed · How we verify
NCT02801825: AxFemArt
Ultrasound-guided Axillary Artery vs Femoral Artery Cannulation.
NA trial testing Real-time ultrasound-guided in-plane infraclavicular axillary artery cannulation. in Critical Illness in 110 participants. Completed in 1 August 2021.
1 October 2020
Quick facts
| Lead sponsor | Uniwersytecki Szpital Kliniczny w Opolu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 22 January 2018 |
| Primary completion | 1 October 2020 |
| Estimated completion | 1 August 2021 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Real-time ultrasound-guided in-plane infraclavicular axillary artery cannulation.
- Real-time ultrasound-guided out-of-plane femoral artery cannulation.
Conditions studied
- Critical Illness — all drugs for Critical Illness →
Sponsor
Uniwersytecki Szpital Kliniczny w Opolu — full company profile →
Who can join
18 and older, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main purpose of the study is to compare two ultrasound-guided arterial cannulation procedures: in-plane infraclavicular axillary artery cannulation and out-of-plane femoral artery cannulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02801825
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Critical Illness
Currently open trials in the same condition.
- NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
- NCT07418242 — Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients · recruiting
- NCT07101640 — PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysp · Phase 1, PHASE2 · recruiting
- NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
- NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting
Other Uniwersytecki Szpital Kliniczny w Opolu trials
Trials by the same sponsor.
- NCT06188039 — Superior Vena Cava Collapsibility Index for Predicting Fluid Responsiveness During High-risk Non-cardiac Surgery · NA · completed
- NCT06174610 — Changes of Renal Resistive Index in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. · recruiting
- NCT06729268 — Fluid Responsiveness Tests in Critically Ill Patients During Admission to the Intensive Care Unit · completed
- NCT05657678 — Vitamin D3 Supplementation in Critically Ill Patients Undergoing CRRT · Phase 4 · recruiting
- NCT03412422 — Ultrasound Assessment of Changes in the Diameter of the Common Carotid Artery After Increasing the Preload of the Heart · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02801825 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uniwersytecki Szpital Kliniczny w Opolu
- Last refreshed: 21 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02801825.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing